Karsten Stahnke

Activation of apoptosis pathways in peripheral blood lymphocytes by in vivo chemotherapy

Karsten Stahnke, Simone Fulda, Claudia Friesen et al. · Blood · 2001 · 115 citations · Full text

Life Sciences, Cell Biology, Immunology +15

Pharmacokinetics of native <i>Escherichia coli</i> asparaginase (Asparaginase medac) and hypersensitivity reactions in ALL‐BFM 95 reinduction treatment

Hans‐Joachim Müller, Rita Beier, Lutz Löning et al. · British Journal of Haematology · 2001 · 95 citations

Life Sciences, Immunology, Pharmacokinetics +13

Early Relapse in ALL Is Identified by Time to Leukemia in NOD/SCID Mice and Is Characterized by a Gene Signature Involving Survival Pathways

Lüder Hinrich Meyer, Sarah M. Eckhoff, Manon Queudeville et al. · Cancer Cell · 2011 · 92 citations · Full text

Medicine, Molecular Biology, Oncology +14

Duration of first remission predicts remission rates and long-term survival in children with relapsed acute myelogenous leukemia

Karsten Stahnke, Joachim Boos, Christine Bender‐Götze et al. · Leukemia · 1998 · 89 citations

Medicine, Hematology, Pediatrics +11

Caspase-8L expression protects CD34+ hematopoietic progenitor cells and leukemic cells from CD95-mediated apoptosis

Andrea Mohr, Ralf M. Zwacka, Gergely Jármy et al. · Oncogene · 2005 · 57 citations

Life Sciences, Cell Biology, Hematology +11